The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of pazopanib and sunitinib as first-line therapy for patients with advanced/metastatic renal cell carcinoma in a U.S. community oncology setting.
 
Bradford Richard Hirsch
Employment - US Oncology
Leadership - US Oncology
Consulting or Advisory Role - Astellas Pharma; Genentech; Hospira; Pfizer; Sandoz
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Hospira; Sandoz
 
Xiaolong Jiao
Research Funding - Pfizer (Inst)
 
Thomas Wilson
Employment - Wilson Research Group, LLC
Leadership - Trajectory Healthcare
Stock and Other Ownership Interests - Trajectory Healthcare
Consulting or Advisory Role - McKesson
Research Funding - McKesson
Patents, Royalties, Other Intellectual Property - Trajectory Healthcare
 
Michelle Denise Hackshaw
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Eric Jonasch
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Exelixis; GlaxoSmithKline; Novartis; Onyx; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer
 
Sameer Ghate
Employment - Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Jose Ricardo Perez
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Cerulean Pharma; Janssen Biotech; Labceutics; Pfizer
Speakers' Bureau - Bayer; Caris MPI; Dendreon; Genentech/Roche; GlaxoSmithKline; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology